Madrigal Pharmaceuticals, Inc. (MDGL) stock
MDGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/304% above fair value
$398.08−23.91 (-5.67%)
Close on Nov 18, 2026Market cap $9.20BP/E –Yield –
Madrigal Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Madrigal Pharmaceuticals's pe ratio was 2.0× on Feb 28, 2011.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2011 | Feb 28, 2011 | 2.0× | −0.2 |
| 2010 | Dec 31, 2010 | 2.1× | – |
See a number that looks wrong?